These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Portal and systemic venous drainage in pancreas and kidney-pancreas transplantation: early surgical complications and outcomes.
    Author: Quintela J, Aguirrezabalaga J, Alonso A, Fernandez C, Corbal G, Gomez M.
    Journal: Transplant Proc; 2009; 41(6):2460-2. PubMed ID: 19715951.
    Abstract:
    OBJECTIVE: The objective of this study was to perform a retrospective analysis of the clinical evolution and surgical complications comparing pancreas transplantation with systemic-enteric (SE) drainage versus portal-enteric (PE) drainage. METHODS: This review of 48 consecutive pancreas transplantation includes 39 simultaneous kidney and pancreas (SKP) and 9 pancreas after kidney (PAK) grafts as well as 2 retransplantations. Venous drainage was systemic (n = 29) or portal (n = 19). RESULTS: There were no significant differences in patient, kidney, or pancreas allograft survival rates. There were no significant differences in levels of creatinine, fasting glucose, C-peptide, cholesterol, and homeostatic model assessment (HOMA) of beta cells, namely HOMA-s and HOMA-IR index. HbA1c was lower at 6 months and 1 year in the PE group (P < .05). Twenty-two patients displayed early postoperative complications at a mean time of presentation of 12.8 days. All of these patients but 2 needed relaparotomy. The other two were treated either conservatively (1 enteric fistula) or by interventional radiology (arteriovenous fistula). There were 10 graft losses, 5 in each group, due to thrombosis, pancreatitis, and enteric fistulae. CONCLUSION: Early graft losses were related to pancreatitis and thrombosis. Intermediate-term endocrine function was similar in both groups.
    [Abstract] [Full Text] [Related] [New Search]